Yuvraj

Bone Therapeutics to build new manufacturing facility in Belgium

Biopharmaceutical company Bone Therapeutics has announced that it has made a €10m investment in Skeletal Cell Therapy Support (SCTS) to build a new...

Mylan Pharmaceuticals launches Fenofibrate Capsules

Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP, 43 mg and 130 mg. ...

Okairos Initiates Phase I Clinical Trial Evaluating Vaccine against RSV Infections

Okairos today announced the initiation of a Phase I clinical trial evaluating a vaccine against respiratory syncytial virus (RSV), a leading cause of...

FDA approves Roche’s Kadcyla (trastuzumab emtansine), the first antibody-drug conjugate for treating HER2-positive metastatic breast cancer

Roche announced that the U.S. Food and Drug Administration (FDA) has approved Kadcyla (trastuzumab emtansine or T-DM1) for the treatment of people with...

Ablynx inks deal with Spirogen to evaluate novel anti-cancer drug conjugate

Ablynx has signed a collaborative agreement with Spirogen to evaluate the potential of a novel anti-cancer drug conjugate. As...

UCB, ConfometRx sign drug discovery research deal

Belgium-based biopharmaceutical company UCB has signed a research deal with ConfometRx for the discovery of new drugs. Under the...

M*Modal, Intermountain Healthcare partner to develop mobile order entry app

Clinical documentation and Speech Understanding solutions provider M*Modal has signed an agreement with Intermountain Healthcare to jointly develop innovative mobile technology for speech-enabled...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read